Studies of COVID-19 convalescents 3–5 months post-infection have revealed maintained high levels of IL-6 associated with persistence of symptoms [4] and a study of autoantibody levels in serum found a high frequency of antibodies against the skin, skeletal muscle and cardiac tissue [5]. The gene discussed is IL6; the disease is COVID-19.